Form EFFECT Lucid Diagnostics Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 26, 2026 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GPOPlus+ (OTCQB:GPOX) Releases Retail Investor Memo Highlighting Proven DSD Model, 6x Revenue Growth, and Scalable Path in $50B Underserved Market
- As Global Demand for Electric Vehicles Accelerates Amid Rising Fuel Costs, Growing Numbers of Investors Worldwide Are Discovering ELEKTROS Inc.'s Vision for Lithium Mining, Critical Minerals, and Pate
- Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
